PCN57 Budget IMPACT Analysis of Trifluridine/Tipiracil (FTD/TPI) As a Third-LINE Treatment of Metastatic Gastric Cancer, Including Adenocarcinoma of the Gastroesophageal Junction, Among Patients WHO Have Received at Least Two PRIOR Therapies for Metastatic Disease in Greece

Authors :: P. Papakotoulas
M. Koulentaki
G Gourzoulidis
Georgia Kourlaba
N. Androulakis
M. Karamouzis
Anna Koumarianou
E. Samantas
V. Chotzagiannoglou
I. Boukovinas
Alexandra Beletsi
S. Xynogalos
I Souglakos
Source :: Value in Health. 23:S431-S432
Publication Year :: 2020
Publisher :: Elsevier BV, 2020.

Subjects :: Oncology
medicine.medical_specialty
business.industry
Health Policy
Public Health, Environmental and Occupational Health
Disease
Budget impact
medicine.disease
Gastroesophageal Junction
Metastatic gastric cancer
Internal medicine
Medicine
Adenocarcinoma
business
Third line treatment

Full Text Access

Tools